Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bernard

Showing results (521-530 of 564) with videos related to

Pageof 57
Sort By:
The Journal of Infectious Diseases|March 29, 2002
Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infectionGalit Alter, Alefia Merchant, Christos M Tsoukas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137LJacob Bukczynski, Tao Wen, Chao Wang, et al.
European Journal of Nuclear Medicine|July 10, 1999
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amountM de Jong, W A Breeman, B F Bernard, et al.
Bone Marrow Transplantation|February 19, 2014
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA studyF Bernard, P Auquier, I Herrmann, et al.
European Journal of Nuclear Medicine|April 1, 1997
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapyM de Jong, W H Bakker, E P Krenning, et al.
European Journal of Nuclear Medicine|July 1, 1995
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapyM de Jong, W A Breeman, B F Bernard, et al.
Viruses|March 26, 2022
Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite ControllersStéphane Isnard, Léna Royston, John Lin, et al.
Clinical Immunology (Orlando, Fla.)|May 25, 2007
Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progressionYoav Peretz, Michel L Ndongala, Salix Boulet, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumorsPaul J J M Janssen, Moniaue de Visser, Suzanne M Verwijnen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.
Pageof 57

Showing results (521-530 of 564) with videos related to

Sort By:
Pageof 57
The Journal of Infectious Diseases|March 29, 2002
Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infectionGalit Alter, Alefia Merchant, Christos M Tsoukas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137LJacob Bukczynski, Tao Wen, Chao Wang, et al.
European Journal of Nuclear Medicine|July 10, 1999
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amountM de Jong, W A Breeman, B F Bernard, et al.
Bone Marrow Transplantation|February 19, 2014
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA studyF Bernard, P Auquier, I Herrmann, et al.
European Journal of Nuclear Medicine|April 1, 1997
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapyM de Jong, W H Bakker, E P Krenning, et al.
European Journal of Nuclear Medicine|July 1, 1995
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapyM de Jong, W A Breeman, B F Bernard, et al.
Viruses|March 26, 2022
Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite ControllersStéphane Isnard, Léna Royston, John Lin, et al.
Clinical Immunology (Orlando, Fla.)|May 25, 2007
Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progressionYoav Peretz, Michel L Ndongala, Salix Boulet, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumorsPaul J J M Janssen, Moniaue de Visser, Suzanne M Verwijnen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.
Pageof 57